EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.4.2.26 | Adenoma, Pleomorphic |
27732748 |
The relationship between proteoglycan inhibition via xylosyltransferase II silencing and the implantation of salivary pleomorphic adenoma. |
ongoing research
unassigned |
2
0 |
| 2.4.2.26 | Astrocytoma |
29157673 |
Circulating microRNAs as Biomarkers for Pediatric Astrocytomas. |
unassigned |
0 |
| 2.4.2.26 | Cardiomyopathy, Dilated |
17635914 |
Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. |
ongoing research
unassigned |
4
0 |
| 2.4.2.26 | Cataract |
26027496 |
Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects. |
causal interaction
unassigned |
4
0 |
| 2.4.2.26 | Cataract |
26987875 |
Spondyloocular Syndrome - Novel Mutations in XYLT2 Gene and Expansion of the Phenotypic Spectrum. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
3
3
0 |
| 2.4.2.26 | Cataract |
27320698 |
Corneal clouding, cataract, and colobomas with a novel missense mutation in B4GALT7-a review of eye anomalies in the linkeropathy syndromes. |
causal interaction
unassigned |
4
0 |
| 2.4.2.26 | Cataract |
27871115 |
Abnormal Proteoglycan Synthesis Due to Gene Defects Causes Skeletal Diseases with Overlapping Phenotypes. |
causal interaction
unassigned |
3
0 |
| 2.4.2.26 | Cysts |
17517600 |
Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 2.4.2.26 | Diabetes Complications |
18789912 |
Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
1
0 |
| 2.4.2.26 | Diabetes Mellitus, Type 1 |
16164625 |
Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
